Restriction fragment length polymorphism study of nationwide samples of Mycobacterium tuberculosis in Thailand, 1997-1998

International Journal of Tuberculosis and Lung Disease

Volumn 9, Issue 5, 2005, Pages 576-581

  Rienthong, D ^a   Ajawatanawong, P ^b   Rienthong, S ^a   Smithtikarn, S ^a   Akarasewi, P ^a   Chaiprasert, A ^c   Palittapongarnpim, Prasit ^b,d,e  

^a Tuberculosis Division   (Thailand)

^b NATIONAL SCIENCE AND TECHNOLOGY DEVELOPMENT AGENCY   (Thailand)

^c MAHIDOL UNIVERSITY   (Thailand)

^d Mahidol University   (Thailand)

^e MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Drug resistance; Molecular epidemiology; RFLP; Thailand; Tuberculosis

Indexed keywords

RIFAMPICIN; STREPTOMYCIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM ISOLATE; EPIDEMIOLOGICAL DATA; GEOGRAPHIC DISTRIBUTION; HEALTH SURVEY; HUMAN; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; THAILAND; TUBERCULOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CLUSTER ANALYSIS; DNA, BACTERIAL; EPIDEMIOLOGY, MOLECULAR; FEMALE; HUMANS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; THAILAND;

EID: 18444377595     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. van Embden J D, Cave M D, Crawford J T, et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol 1993; 31: 406-409.
2. Palittapongarnpim P, Luangsook P, Tansuphaswadikul S, Chuchottaworn C, Prachaktam R, Sathapatayavongs B. Restriction fragment length polymorphism study of Mycobacterium tuberculosis in Thailand using IS6110 as probe. Int J Tuberc Lung Dis 1997; 1: 370-376.
3. Mongkoljit S, Saringearingul H, Smittipat N, Thong-On A, Palittapongarnpim P. Evidence for the transmission of tuberculosis in a prison in Nakhon Ratchasima, Thailand. Int J Tuberc Lung Dis 2001; 5: 586-587.
4. Sretrirutchai S, Silapapojakul K, Palittapongarnpim P, Phongdara A, Vuddhakul V. Tuberculosis in Thai prisons: magnitude, transmission and drug susceptibility. Int J Tuberc Lung Dis 2002; 6: 208-214.
5. Kato-Maeda M, Small P M. How molecular epidemiology has changed what we know about tuberculosis. West J Med 2000; 172: 256-259.
6. Pablos-Mendez A, Raviglione M C, Laszlo A, et al. Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization- International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance. N Engl J Med 1998; 338: 1641-1649.
7. Payanandana V, Rienthong D, Rienthong S, Ratanavichit L, Kim S J, Sawert H. Surveillance for antituberculosis drug resistance in Thailand: results from a national survey. Thai J Tuberc Lung Dis 2000; 21: 1-8.
8. The WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance. Anti-tuberculosis drug resistance in the world. Report No 2. Prevalence and trends. Geneva, Switzerland: WHO, 2000.
9. van Soolingen D, Qian L, de Haas P E, et al. Predominance of a single genotype of Mycobacterium tuberculosis in countries of east Asia. J Clin Microbiol 1995; 33: 3234-3238.
10. McHugh T D, Gillespie S H. Nonrandom association of IS6110 and Mycobacterium tuberculosis: implications for molecular epidemioiogical studies. J Clin Microbiol 1998; 36: 1410-1413.
11. Dale J W, Al-Ghusem H, Al-Hashmi S, et al. Evolutionary relationships among strains of Mycobacterium tuberculosis with few copies of IS6110. J Bacteriol 2003; 185: 2555-2562.
12. Anh D D, Borgdorff M W, Van L N, et al. Mycobacterium tuberculosis Beijing genotype emerging in Vietnam. Emerg Infect Dis 2000; 6: 302-305.
13. Borgdorff M W. Mycobacterium tuberculosis Beijing genotype, the Netherlands. Emerg Infect Dis 2003; 9: 1310-1313.
14. Dale J W, Nor R M, Ramayah S, Tang T H, Zainuddin Z F. Molecular epidemiology of tuberculosis in Malaysia. J Clin Microbiol 1999; 37: 1265-1268.
15. Bifani P J, Plikaytis B B, Kapur V, et al. Origin and interstate spread of a New York City multidrug-resistant Mycobacterium tuberculosis clone family. JAMA 1996; 275: 452-457.
16. Glynn J R, Whiteley J, Bifani P J, Kremer K, van Soolingen D. Worldwide occurrence of Beijing/W strains of Mycobacterium tuberculosis: a systematic review. Emerg Infect Dis 2002; 8: 843-849.
17. Toungoussova O S, Mariandyshev A, Bjune G, Sandven P, Caugant D A. Molecular epidemiology and drug resistance of Mycobacterium tuberculosis isolates in the Archangel prison in Russia: predominance of the W-Beijing clone family. Clin Infect Dis 2003; 37: 665-672.
18. Tracevska T, Jansone I, Baumanis V, Marga O, Lillebaek T. Prevalence of Beijing genotype in Latvian multidrug-resistant Mycobacterium tuberculosis isolates. Int J Tuberc Lung Dis 2003; 7: 1097-1103.
19. Kruuner A, Hoffner S E, Sillastu H, et al. Spread of drug-resistant pulmonary tuberculosis in Estonia. J Clin Microbiol 2001; 39: 3339-3345.
20. Rad M E, Bifani P, Martin C, et al. Mutations in putative mutator genes of Mycobacterium tuberculosis strains of the W-Beijing family. Emerg Infect Dis 2003; 9: 838-845.
21. Werngren J, Hoffner S E. Drug-susceptible Mycobacterium tuberculosis Beijing genotype does not develop mutation-conferred resistance to rifampin at an elevated rate. J Clin Microbiol 2003; 41: 1520-1524.
22. Alland D, Kalkut G E, Moss A R, et al. Transmission of tuberculosis in New York City. An analysis by DNA fingerprinting and conventional epidemiologic methods. N Engl J Med 1994; 330: 1710-1716.